Matthew Lentini

Matthew Lentini is a Senior Research Associate at CRISPR Therapeutics, with a proven track record in developing and optimizing cell-based LNP potency assays and performing critical laboratory techniques such as DNA extraction and PCR. Previously, Matthew held positions in analytical development and quality control roles at Sanofi and Associates of Cape Cod, focusing on microbiology and endotoxin testing. Matthew's early career included laboratory technician work in LAL manufacturing and hazardous waste management at Clean Harbors. Matthew earned a Bachelor of Science in Chemistry from William & Mary and is currently pursuing a Master of Science in Biotechnology at Northeastern University, expected to graduate in April 2024.